← Back to patent-cliff list
CAS 146924-94-9
(3R,4S)-3-Hydroxy-1-(4-methoxyphenyl)-4-phenylazetidin-2-one
Codes：(I)140605-34-a
Application context (from source-drug indications)
膀胱癌多西他赛纳米胶束 (Samyang Biopharmaceuticals)头颈癌多西他赛纳米胶束 (Samyang Biopharmaceuticals)头颈部鳞状细胞癌多西他赛纳米胶束 (Samyang Biopharmaceuticals)实体瘤多西他赛纳米胶束 (Samyang Biopharmaceuticals)
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 多西他赛纳米胶束 (Samyang Biopharmaceuticals)Docetaxel polymeric micelle (Samyang Biopharmaceuticals) | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(3R,4S)-3-Hydroxy-1-(4-methoxyphenyl)-4-phenylazetidin-2-one→(Pentane-1,5-diyl)bis[chlorodi(propan-2-yl)silane]→(3R,4S,3'R,4'S)-3,3'-(Pentane-1,5-diylbis[[di(propan-2-yl)silanediyl]oxy])bis[1-(4-methoxyphenyl)-4-phenylazetidin-2-one]→(3R,4S,3'R,4'S)-3,3'-(Pentane-1,5-diylbis[[di(propan-2-yl)silanediyl]oxy])bis(4-phenylazetidin-2-one)→Di-tert-butyl (3R,4S,3'R,4'S)-3,3'-(pentane-1,5-diylbis[[di(propan-2-yl)silanediyl]oxy])bis(2-oxo-4-phenylazetidine-1-carboxylate)
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.